3H-1,2,4-Triazol-3-one,4-(4-bromophenyl)-2-[(1S,2R)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-methylpropyl]-2,4-dihydro- (214117-52-9)

Identification
Name:	3H-1,2,4-Triazol-3-one,4-(4-bromophenyl)-2-[(1S,2R)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-methylpropyl]-2,4-dihydro-
CAS:	214117-52-9
Molecular Formula:	C₁₈H₂₈BrN₃O₂Si
Molecular Structure:
Properties
Safety Data

Other Product

3H-1,2,4-Triazol-3-one,4-(4-bromophenyl)-2-[(1R,2S)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-methylpropyl]-2,4-dihydro-
3H-1,2,4-Triazol-3-one,4-(4-bromophenyl)-2,4-dihydro-2-[(1S,2R)-2-hydroxy-1-methylpropyl]-
3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-[(1S,2R)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-methylpropyl]-2,4-dihydro-
3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-[(1S)-1-methylpropyl]-
4(1H)-Pyridinone,2-[6-[[(1,1-dimethylethyl)dimethylsilyl]oxy]hexyl]-2,3-dihydro-5-iodo-1-[(E)-[[(1S)-1-(methoxymethyl)-2-methylpropyl]imino]phenylmethyl]-, (2R)-
3H-1,2,4-Triazol-3-one,4-(4-bromophenyl)-2,4-dihydro-2-[(1R,2R)-1-methyl-2-(sulfooxy)propyl]-, potassium salt
1-Pyrrolidinecarboxamide,N-(3-chloro-4-cyano-2-methylphenyl)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-[(1S)-1-hydroxy-2-methylpropyl]-, (2R,3R)-
4(3H)-Quinazolinone,3-amino-2-[(1S)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-
2-Cyclopenten-1-one,2-[(1S)-3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-1-methylpropyl]-4-methyl-, (4S)-
Cyclopentanol,3-[(3S)-3-cyclohexyl-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-propynyl]-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-[(4-pentynylthio)methyl]-,(1S,2R,3S,4R)-
Cyclopentanol,3-[(3S)-3-cyclohexyl-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-propynyl]-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-[(2-propynylthio)methyl]-,(1S,2R,3S,4R)-
4,12-Dioxa-3,13-disilapentadecan-7-one,9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-[(1S)-4-[(2R,3S)-3-[(2S,3E)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-methyl-4-(2-methyl-4-thiazolyl)-3-butenyl]-2-(fluoromethyl)oxiranyl]-1-methylbutyl]-2,2,3,3,6,8,8,13
6-BroMo-1-[(1S)-1-[[[(1,1-diMethylethyl)diMethylsilyl]oxy]Methyl]-2-Methylpropyl]-7-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester
3-Quinolinecarboxylic acid, 1-[(1S)-1-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2-methylpropyl]-7-fluoro-1,4-dihydro-6-iodo-4-oxo-, ethyl ester
2-Butanol, 4-azido-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (2R)-
3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-methylpropyl)-, rel-
3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-[(1R,2R)-2-hydroxy-1-methylpropyl]-
3H-1,2,4-Triazol-3-one,2,4-dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-2-(1-methylpropyl)-
3H-1,2,4-Triazol-3-one,2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-2-(1-methylpropyl)-
3H-1,2,4-TRIAZOL-3-ONE, 2,4-DIHYDRO-4-[4-[4-(4-METHOXYPHENYL)-1-PIPERAZINYL]PHENYL]-2-(1-METHYLPROPYL)-, (R)-